Skip to main content

Table 4 Adherence comparison between participants/non-participants and participants with reliable EM data and participant dropouts

From: Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients

 

Variable

Subgroups

Non-participants

 

Non-participants

Participants

  

median

iqr b

n

median

iqr

n

 

Self-report a

0.0

0.0

65

0.0

0.0

284

 

Collateral report a

1.0

0.1

35

1.0

0.3

164

 

Assay: cyclosporine (mmol/l)

112.5

50.0

50

105.0

56.0

191

 

Assay: tacrolimus (mmol/l)

7.6

3.2

21

7.2

3.9

44

 

Assay: sirolimus (mmol/l)

14.3

4.2

5

8.8

9.5

15

 

Assay: mycophenolate mofetil (mmol/l)

3.3

1.8

41

2.6

1.9

122

Dropouts

 

Non-adherers to the EM guidelines

Adherers to the EM-guidelines

  

median

iqr

n

median

iqr

n

 

Self-report

0.0

0.0

36

0.0

0.0

244

 

Collateral report

1.0

0.7

35

1.0

0.3

224

 

Assay: cyclosporine (mmol/l)

108.0

43.0

25

104.5

58.5

164

 

Assay: tacrolimus (mmol/l)

6.2

6.1

5

7.2

3.7

39

 

Assay: mycophenolate mofetil (mmol/l)

2.7

1.8

17

2.6

1.9

101

  1. a Definition: see section variables and measurement
  2. b Interquartile range